Mammies Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.50 Cr
- Satisfied Charges ₹ 4.00 M
- Revenue Growth -14.93%
- Profit Growth -24.64%
- Ebitda -67.45%
- Net Worth 39.23%
- Total Assets 29.28%
About Mammies Healthcare Products
Mammies Healthcare Products Private Limited (MHPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 April 2018 (Six years and nine months 30 days old ). Its registered office is in Kollam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 Cr. The company has closed loans amounting to ₹4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Salma Nazim and Saiju Nizar serve as directors at the Company.
Company Details
-
Location
Kollam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999KL2018PTC052758
-
Company No.
052758
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Apr 2018
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Mammies Healthcare Products?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Salma Nazim
|
Director | 04-Apr-2018 | Current |
|
Saiju Nizar
|
Director | 04-Apr-2018 | Current |
Financial Performance of Mammies Healthcare Products.
Mammies Healthcare Products Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.93% decrease. The company also saw a substantial fall in profitability, with a 24.64% decrease in profit. The company's net worth Soared by an impressive increase of 39.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mammies Healthcare Products?
In 2021, Mammies Healthcare Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹35.00 M
₹4.00 M
Charges Breakdown by Lending Institutions
- Others : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2024 | Others | ₹1.25 Cr | Open |
| 29 Nov 2022 | Others | ₹2.25 Cr | Open |
| 14 Jun 2018 | Others | ₹4.00 M | Satisfied |
How Many Employees Work at Mammies Healthcare Products?
Unlock and access historical data on people associated with Mammies Healthcare Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mammies Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mammies Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.